Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004479 · ClinicalTrials.gov registry record · NA
Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
NCT00004479 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai.
The verdict
NCT00004479, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
OBJECTIVES: Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.
Interventions
- DRUG midodrine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004479
The ClinicalTrials.gov registry entry for NCT00004479 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which midodrine is the first listed.
NCT00004479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004479 about?
NCT00004479 is a clinical study titled "Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope". OBJECTIVES: Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.
What is the current status of trial NCT00004479?
This trial is currently completed. It is a NA study. The study started on 1999-03.
What interventions are being tested in trial NCT00004479?
The interventions under investigation include: midodrine (DRUG).
Who is sponsoring clinical trial NCT00004479?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.